Editorial
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System
Bioanalysis · 2023
DOI: 10.4155/bio-2023-0170 ↗Kurz gefasst
Editorial in der Zeitschrift Bioanalysis, 2023. Verfasst von Ming Li. Beteiligte Einrichtung: Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA. Hauptthemen laut MEDLINE: Laboratories, Drug Industry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
LaboratoriesDrug Industry
Autor:innen und Institutionen
- Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA.
Zitieren
APA
Li, M. (2023). Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System. Bioanalysis. https://doi.org/10.4155/bio-2023-0170
Vancouver
Li M. Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System. Bioanalysis. 2023. doi:10.4155/bio-2023-0170
BibTeX
@article{Li2023,
author = {Li, Ming},
title = {Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System},
journal = {Bioanalysis},
year = {2023},
doi = {10.4155/bio-2023-0170}
}
EUVIMED